Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography

British Journal of Oral and Maxillofacial Surgery

Volumn 46, Issue 3, 2008, Pages 180-186

  Li, Sheng jiao ^a   Guo, Wei ^a   Ren, Guo xin ^a   Huang, Gang ^b   Chen, Tao ^b   Song, Shao li ^b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

2 18F fluoro 2 deoxy D glucose; Glucose transporter 1; Head and neck squamous cell carcinomas; Positron emission tomography; Standardised uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANIMALS; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE TRANSPORTER TYPE 1; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RABBITS; RADIOPHARMACEUTICALS; TUMOR MARKERS, BIOLOGICAL;

EID: 40349093071     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2007.11.003     Document Type: Article

References (24)

1. Lindholm P., Minn H., Leskinen-Kallio S., Bergman J., Ruotsalainen U., and Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer-a PET study. J Nucl Med 34 (1993) 1-6
2. Higashi T., Saga T., Nakamoto Y., et al. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 43 (2002) 173-180
3. Brown R.S., Goodman T.M., Zasadny K.R., Greenson J.K., and Wahl R.L. Expression of hexokinase II and Glut-1 in untreated human breast cancer. Nucl Med Biol 29 (2002) 443-453
4. Mellanen P., Minn H., Grenman R., and Härkönen P. Expression of glucose transporters in head-and-neck tumors. Int J Cancer 56 (1994) 622-629
5. Marom E.M., Aloia T.A., Moore M.B., et al. Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer. Lung Cancer 33 (2001) 99-107
6. Higashi T., Tamaki N., Honda T., et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study. J Nucl Med 38 (1997) 1337-1344
7. Higashi T., Tamaki N., Torizuka T., et al. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors. J Nucl Med 39 (1998) 1727-1735
8. 18F]FDG uptake in non-small cell lung cancer. Eur J Nucl Med 27 (2000) 1778-1785
9. Gu J., Yamamoto H., Fukunaga H., et al. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer. Dig Dis Sci 51 (2006) 2198-2205
10. Tateishi U., Yamaguchi U., Seki K., Terauchi T., Arai Y., and Hasegawa T. Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography. Eur J Nucl Med Mol Imaging 33 (2006) 683-691
11. Tian M., Zhang H., Nakasone Y., Mogi K., and Endo K. Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study. Eur J Nucl Med Mol Imaging 31 (2004) 5-12
12. Woo M.M., Alkushi A., Verhage H.G., et al. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer. Clin Cancer Res 10 (2004) 7958-7964
13. Mochiki E., Kuwano H., Katoh H., Asao T., Oriuchi N., and Endo K. Evaluation of 18F-2-deoxy-2-fluoro-d-glucose positron emission tomography for gastric cancer. World J Surg 28 (2004) 247-253
14. Yen T.C., See L.C., Lai C.H., et al. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. J Nucl Med 45 (2004) 22-29
15. Kurokawa T., Yoshida Y., Kawahara K., et al. Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary. Int J Cancer 109 (2004) 926-932
16. Gourin C.G., Williams H.T., Seabolt W.N., Herdman A.V., Howington J.W., and Terris D.J. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. Laryngoscope 116 (2006) 705-710
17. Kallinowski F., Schlenger K.H., Runkel S., et al. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res 49 (1989) 3759-3764
18. Heber D., Byerley L.O., and Tchekmedyian N.S. Hormonal and metabolic abnormalities in the malnourished cancer patient: effects on host-tumour interaction. JPEN 16 6 suppl (1992) 60S-64S
19. Kunkel M., Reichert T.E., Benz P., et al. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 97 (2003) 1015-1024
20. Younes M., Lechago L.V., and Lechago J. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. Clin Cancer Res 2 (1996) 1151-1154
21. Baer S., Casaubon L., Schwartz M.R., Marcogliese A., and Younes M. Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival. Laryngoscope 112 (2002) 393-396
22. Oliver R.J., Woodwards R.T., Sloan P., Thakker N.S., Stratford I.J., and Airley R.E. Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Translational Research Fund studies. Eur J Cancer 40 (2004) 503-507
23. Minn H., Lapela M., Klemi P.J., et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 38 (1997) 1907-1911
24. Rege S., Safa A.A., Chaiken L., Hoh C., Juillard G., and Withers H.R. Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas. Am J Clin Oncol 23 (2000) 164-169